Latest News by Industry
RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Thursday reported a loss of $12.2 million in its fourth quarter.
The Ramsey, New Jersey-based company said it had a loss of 6 cents per share.
The infectious disease drug developer posted revenue of $50 million in the period.
For the year, the company reported that its loss narrowed to $65.9 million, or 33 cents per share. Revenue was reported as $154.1 million.
Adma Biologics expects full-year revenue of $210 million.
In the final minutes of trading on Thursday, the company's shares hit $3.11. A year ago, they were trading at $1.46.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a ADMA">Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA